Eligi
Med
Ensayos clínicos
Suscripción
Sobre EligiMed
Ensayos Clínicos de Obstetricia y Ginecología | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Completado
RENIS
EVALUACIÓN DE ESTRATEGIAS DE ABORDAJE DE LA SALUD MENTAL Y SUBJETIVIDAD DEL RECIEN NACIDO PREMATURO EN EL HOSPITAL POSADAS. ESTUDIO CUALITATIVO
OBSERVATIONAL
ID: IS000454
Completado
RENIS
Mortalidad neonatal en recién nacidos <1500 gramos: estudio multicéntrico
OBSERVATIONAL
ID: IS000452
Suspendido
RENIS
Ensayo clínico con terapia Hormonal en pacientes post menopausicas
INTERVENTIONAL
ID: IS000449
Activo, no recluta
RENIS
Cuidados durante el embarazo en mujeres primerizas.
OBSERVATIONAL
ID: IS000431
Completado
RENIS
Factores que intervienen en el proceso de toma de decisión frente a un embarazo no aceptado. Estudio exploratorio en mujeres mayores de 18 años que concurren al Servicio de Obstetricia del Hospital General de Agudos Dr. Teodoro Álvarez
OBSERVATIONAL
ID: IS000378
Completado
RENIS
Protocolo para Estudio Fase 3 de FK463 ISN/Protocolo 9463-CL-2303
INTERVENTIONAL
ID: IS000367
Completado
RENIS
Determinación de valores normales en dimensiones cardíacas fetales en el tercer trimestre de la gestación.
OBSERVATIONAL
ID: IS000161
Completado
RENIS
Marcadores séricos en preeclampsia
OBSERVATIONAL
ID: IS000159
Completado
RENIS
Encuesta global. Morbilidad materna severa
OBSERVATIONAL
ID: IS000098
Completado
RENIS
Ensayo Clínico Aleatorizado, a Ciegas y Controlado con Placebo, de la Aplicacion Perilesional del CIGB-300 en Dos Niveles de Dosis en la Condilomatosis Genital Recidivante y No Recidivantes
INTERVENTIONAL
ID: IS000009
Completado
Fase 3
ClinicalTrials.gov
A Phase III Study of Novel Epothilone (Ixabepilone) Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast Cancer Previously Treated With an Anthracycline and a Taxane
INTERVENTIONAL
Inicio: 1 de nov de 2003
ID: NCT00082433
Desconocido
ClinicalTrials.gov
Looking For Genetic and Environmental Risk Factors and Therapeutic Aspects in Cervical Artery Dissections
OBSERVATIONAL
Inicio: 1 de jul de 2005
ID: NCT00657969
Terminado
Fase 2
ClinicalTrials.gov
Randomized, Placebo Controlled, Double Blind Phase 1b/2 Study of U3-1287 (AMG 888) in Combination With Trastuzumab Plus Paclitaxel in Newly Diagnosed HER2 Positive Metastatic Breast Cancer (MBC)
INTERVENTIONAL
Inicio: 1 de nov de 2011
ID: NCT01512199
Activo, no recluta
Fase 3
ClinicalTrials.gov
A Phase III Multi-center, Randomized, Open-label Trial to Evaluate Efficacy and Safety of Ribociclib With Endocrine Therapy as an Adjuvant Treatment in Patients With Hormone Receptor-positive, HER2-negative Early Breast Cancer (New Adjuvant TriAl With Ribociclib [LEE011]: NATALEE)
INTERVENTIONAL
Inicio: 7 de dic de 2018
ID: NCT03701334
Activo, no recluta
Fase 2
ClinicalTrials.gov
A Randomized, Open-Label, Phase 2 Study of Abemaciclib Plus Tamoxifen or Abemaciclib Alone, in Women With Previously Treated Hormone Receptor-Positive, HER2-Negative, Metastatic Breast Cancer
INTERVENTIONAL
Inicio: 14 de sept de 2016
ID: NCT02747004
Terminado
Fase 3
ClinicalTrials.gov
eMonarcHER: A Randomized, Double Blind, Placebo-Controlled Phase 3 Study of Abemaciclib Plus Standard Adjuvant Endocrine Therapy in Participants With High-Risk, Node-Positive, HR+, HER2+ Early Breast Cancer Who Have Completed Adjuvant HER2-Targeted Therapy
INTERVENTIONAL
Inicio: 10 de may de 2021
ID: NCT04752332
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Open-Label, Phase III Study of Taxane Based Chemotherapy With Lapatinib or Trastuzumab as First-Line Therapy for Women With HER2/Neu Positive Metastatic Breast Cancer
INTERVENTIONAL
Inicio: 7 de oct de 2008
ID: NCT00667251
Terminado
Fase 4
ClinicalTrials.gov
Efficacy and Safety of Two Different Botulinum Toxin Type A Treatments for Moderate to Severe Cervical Dystonia
INTERVENTIONAL
Inicio: 1 de jun de 2007
ID: NCT00432341
Activo, no recluta
Fase 3
ClinicalTrials.gov
A Phase 3, Randomized, Active-controlled, Open-label, Multicenter Study to Compare the Efficacy and Safety of MK-2870 Monotherapy Versus Treatment of Physician's Choice in Participants With Endometrial Cancer Who Have Received Prior Platinum-based Chemotherapy and Immunotherapy (MK-2870-005/ENGOT-en23/GOG-3095)
INTERVENTIONAL
Inicio: 6 de dic de 2023
ID: NCT06132958
Completado
Fase 3
ClinicalTrials.gov
Neo ALTTO (Neoadjuvant Lapatinib and/or Trastuzumab Treatment Optimisation) Study: A Randomised, Multicenter Open-label Phase III Study of Neoadjuvant Lapatinib, Trastuzumab and Their Combination Plus Paclitaxel in Women With HER2/ErbB2 Positive Primary Breast Cancer
INTERVENTIONAL
Inicio: 5 de ene de 2008
ID: NCT00553358
Anterior
1
...
4
5
6
...
434
Siguiente
Filtros